Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy | Zendy

Amer M. Zeidan | Zendy; Pierre Fenaux | Zendy; Marco Gobbi | Zendy; Jiřı́ Mayer | Zendy; Gail J. Roboz | Zendy; Jürgen Krauter | Zendy; Tadeusz Robak | Zendy; Hagop M. Kantarjian | Zendy; Jan Novák | Zendy; W Wiktor-Jędrzejczak | Zendy; Xavier Thomas | Zendy; Mario OjedaUribe | Zendy; Yasushi Miyazaki | Zendy; Yoo Hong Min | Zendy; SuPeng Yeh | Zendy; Joseph Brandwein | Zendy; Liana Gercheva | Zendy; Judit Demeter | Zendy; Elizabeth A. Griffiths | Zendy; Karen Yee | Zendy; JeanPierre J. Issa | Zendy; Jan Philipp Bewersdorf | Zendy; Harold Keer | Zendy; Yong Hao | Zendy; Mohammad Azab | Zendy; Hartmut Döhner | Zendy

Open Access

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Author(s) -

Amer M. Zeidan,

Pierre Fenaux,

Marco Gobbi,

Jiřı́ Mayer,

Gail J. Roboz,

Jürgen Krauter,

Tadeusz Robak,

Hagop M. Kantarjian,

Jan Novák,

W Wiktor-Jędrzejczak,

Xavier Thomas,

Mario OjedaUribe,

Yasushi Miyazaki,

Yoo Hong Min,

SuPeng Yeh,

Joseph Brandwein,

Liana Gercheva,

Judit Demeter,

Elizabeth A. Griffiths,

Karen Yee,

JeanPierre J. Issa,

Jan Philipp Bewersdorf,

Harold Keer,

Yong Hao,

Mohammad Azab,

Hartmut Döhner

Publication year - 2022

Publication title -

blood

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.515

H-Index - 465

eISSN - 1528-0020

pISSN - 0006-4971

DOI - 10.1182/blood.2022015832

Subject(s) - azacitidine , decitabine , medicine , chemotherapy regimen , chemotherapy , oncology , intensive care medicine , chemistry , dna methylation , biochemistry , gene expression , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore